RecruitingNot ApplicableNCT06555315

Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)

Pilot Non-inferiority Study Investigating Daily Versus Every Other Day Dosing of Oral Iron in Premature Infants.


Sponsor

CHRISTUS Health

Enrollment

100 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Study focuses on determining if daily versus every-other-day (EOD) oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks post-menstrual age in premature neonates


Eligibility

Min Age: 26 WeeksMax Age: 32 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 6 mg/kg of oral iron as ferrous sulfate administered every day. and 6 mg/kg of oral iron as ferrous sulfate administered every other day. for people with anemia of prematurity, extremely low birth weight, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 26 Weeks to 32 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENT6 mg/kg of oral iron as ferrous sulfate administered every other day.

6mg/kg of oral iron as ferrous sulfate administered every other day instead of 6 mg/kg of oral iron daily supplementation.

DIETARY_SUPPLEMENT6 mg/kg of oral iron as ferrous sulfate administered every day.

6 mg/kg of oral iron as daily ferrous sulfate instead of 6mg/kg of oral iron supplementation administered every other day.


Locations(1)

CHRISTUS Children's

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06555315


Related Trials